Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
The Journal of Antimicrobial Chemotherapy
|
June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
Mycoses
|
September 17, 2025
Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States
Ilana Reinhold, Giovanni Mori, Massimiliano Lanzafame, et al.
Emerging Infectious Diseases
|
February 4, 2021
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020
Jon Salmanton-García, Rosanne Sprute, Jannik Stemler, et al.
Frontiers in Neuroscience
|
November 5, 2019
Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Due to <i>MTMR2</i> Mutations and Implications in Membrane Trafficking
Haicui Wang, Ayşe Kaçar Bayram, Rosanne Sprute, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2025
Glycan microarray analysis of <i>Candida</i>-related antibodies in human and mice sera guides biomarker discovery and vaccine development
Emelie E Reuber, Emer Hickey, Arnab Pradhan, et al.
Mbio
|
September 12, 2025
<i>Aspergillus fumigatus</i> effector crpA orchestrates host prostaglandin signaling to promote fungal virulence
Camila Figueiredo Pinzan, Camila Diehl, Patrícia Alves de Castro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2023
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
Nicola Giesen, Elena Busch, Enrico Schalk, et al.
The Lancet Regional Health. Europe
|
February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
Michael Sandherr, Jannik Stemler, Enrico Schalk, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final report
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
The Journal of Antimicrobial Chemotherapy
|
June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
Mycoses
|
September 17, 2025
Rezafungin Utilisation in Real Life-FungiScope Results From Europe and the United States
Ilana Reinhold, Giovanni Mori, Massimiliano Lanzafame, et al.
Emerging Infectious Diseases
|
February 4, 2021
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020
Jon Salmanton-García, Rosanne Sprute, Jannik Stemler, et al.
Frontiers in Neuroscience
|
November 5, 2019
Genotype-Phenotype Correlations in Charcot-Marie-Tooth Disease Due to <i>MTMR2</i> Mutations and Implications in Membrane Trafficking
Haicui Wang, Ayşe Kaçar Bayram, Rosanne Sprute, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2025
Glycan microarray analysis of <i>Candida</i>-related antibodies in human and mice sera guides biomarker discovery and vaccine development
Emelie E Reuber, Emer Hickey, Arnab Pradhan, et al.
Mbio
|
September 12, 2025
<i>Aspergillus fumigatus</i> effector crpA orchestrates host prostaglandin signaling to promote fungal virulence
Camila Figueiredo Pinzan, Camila Diehl, Patrícia Alves de Castro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2023
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
Nicola Giesen, Elena Busch, Enrico Schalk, et al.
The Lancet Regional Health. Europe
|
February 20, 2025
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies
Michael Sandherr, Jannik Stemler, Enrico Schalk, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final report
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Page
of 7